Risk factors of lymph node metastasis in early gastric carcinomas diagnosed by WHO criteria in 379 Chinese patients

Fang Cheng(Nanjing Drum Tower Hospital), Qin Huang(People's Hospital of Xinjiang Uygur Autonomous Region), Wenjia Liu(Hebei Medical University), Xiao Ping Zou(Nanjing Drum Tower Hospital), Qi Sun(Fudan University), Jiong Shi(Nanjing Drum Tower Hospital), Gui Fang Xu(Nanjing Drum Tower Hospital), Jason S. Gold(Memorial Sloan Kettering Cancer Center)
Journal of Digestive Diseases
July 19, 2016
10.1111/1751-2980.12385
Cited by 35

Related Papers

MYC/BCL2 protein coexpression contributes to the inferior survival of activated B-cell subtype of diffuse large B-cell lymphoma and demonstrates high-risk gene expression signatures: a report from The International DLBCL Rituximab-CHOP Consortium Program
|Blood|2013|683
Development and validation of a prognostic nomogram for recurrence-free survival after complete surgical resection of localised primary gastrointestinal stromal tumour: a retrospective analysis
|The Lancet Oncology|2009|511
Mutational profile and prognostic significance of TP53 in diffuse large B-cell lymphoma patients treated with R-CHOP: report from an International DLBCL Rituximab-CHOP Consortium Program Study
|Blood|2012|396
Cloning of a new member of the peroxisome proliferator-activated receptor gene family from mouse liver.
|Journal of Biological Chemistry|1993|375
Comprehensive gene expression profiling and immunohistochemical studies support application of immunophenotypic algorithm for molecular subtype classification in diffuse large B-cell lymphoma: a report from the International DLBCL Rituximab-CHOP Consortium Program Study
|Leukemia|2012|362